Trials / Active Not Recruiting
Active Not RecruitingNCT03299478
Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 865 (actual)
- Sponsor
- University Hospital of North Norway · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate TNM-Immunoscore in resected non-small cell lung cancer.
Detailed description
The main aim is to validate the most promising T-cell marker candidates from earlier studies in a prospective multicenter study to establish a prognostic TNM-Immunoscore. The investigators will include around 1000 stage I-IIIA patients from various centers in Scandinavia. The investigators will also collect demographic and clinicopathological data, blood and tissues in a database and biobank. Candidate T-cell markers will be analyzed by immunohistochemistry for validation and by other methods for exploration of their impact on prognosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Will look for immune infiltration |
Timeline
- Start date
- 2016-11-28
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2017-10-03
- Last updated
- 2024-06-11
Locations
5 sites across 2 countries: Denmark, Norway
Source: ClinicalTrials.gov record NCT03299478. Inclusion in this directory is not an endorsement.